In what it describes as a “substantial boost” for the UK’s vaccine manufacturing capacity, the government has announced an additional £100m (US$130m) in funding for a state-of-the-art production center for the mass production of vaccines for COVID-19 or other infectious disease crises.
Due to open in December 2021, the Cell and Gene Therapy Catapult Manufacturing Innovation Centre will be able to produce...








